IP Library Granted Patent US 10,807,865
Granted Patent B2
US 10,807,865 · App. 13/421,527 · Granted Oct 20, 2020

Semiconductor nanocrystals

Inventors: Ou Chen (Somerville, MA); Moungi G. Bawendi (Cambridge, MA)
Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
B82Y30/00B82Y20/00C09K11/02C09K11/565C09K11/881
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,807,865
App. No.
13/421,527
Granted
Oct 20, 2020
Kind
B2
Abstract

A method of making a nanocrystal includes slowly infusing a M-containing compound and a X donor into a mixture including a nanocrystal core, thereby forming an overcoating including M and X on the core.

Claims (21)

1. A method of making a nanocrystal comprising:

heating a mixture including a nanocrystal core to between 200° C. and 350° C.; and

while maintaining a constant temperature between 200° C. and 350° C., infusing a calculated amount of a non-organometallic M-containing compound and a X donor together into the mixture including the nanocrystal core, wherein the X donor is an alkyl thiol, at a rate of between 0.03 ml/minute and 0.07 ml/minute, thereby forming an overcoating including M and X on the core.

2. The method of claim 1 , wherein the M-containing compound is a metal salt.

3. The method of claim 2 , wherein the metal salt is a cadmium salt.

4. The method of claim 1 , wherein the X donor is a C 6 to C 18 alkyl thiol.

5. The method of claim 1 , wherein the infusion occurs over a period of 1 minute or longer.

6. The method of claim 5 , wherein the infusion occurs over a period of 10 minutes or longer.

7. The method of claim 6 , wherein the infusion occurs over a period of 30 minutes or longer.

8. The method of claim 1 , wherein infusing occurs continuously.

9. The method of claim 1 , wherein contacting the M-containing compound and the X donor with the nanocrystal core at a slow rate of infusion with a syringe pump.

10. The method of claim 1 , wherein the overcoated nanocrystal photoluminesces with a quantum yield of at least 90% at room temperature.

11. The method of claim 10 , wherein the overcoated nanocrystal photoluminesces with a quantum yield of at least 97% at room temperature.

12. The method of claim 1 , further comprising exposing the overcoated nanocrystal to an organic compound having affinity for a surface of the overcoated nanocrystal.

13. The method of claim 1 , wherein the nanocrystal core includes CdSe.

14. The method of claim 1 , wherein the overcoating includes CdS.

15. The method of claim 1 , wherein the nanocrystal core is a member of a substantially monodisperse population of nanocrystal cores.

16. The method of claim 1 , wherein the overcoated nanocrystal is a member of a substantially monodisperse population of overcoated nanocrystals.

17. The method of claim 16 , wherein the population emits light in a spectral range of no greater than about 34 nm full width at half max (FWHM).

18. The method of claim 17 , wherein the population exhibits less than a 10% rms deviation in diameter of the overcoated nanocrystal.

19. The method of claim 18 , wherein the population exhibits less than a 5% rms deviation in diameter of the overcoated nanocrystal.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 5, 2012
From: MASSACHUSETTS INSTITUTE FOR TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028914/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2012
From: CHEN, OU; BAWENDI, MOUNGI G.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 028094/0468 →
Continuity (1)
Related Publication 20130240787A1 · Sep 19, 2013